Access the full text.
Sign up today, get DeepDyve free for 14 days.
P. Tibbo, A. Malla, R. Manchanda, Richard Williams, R. Joober (2014)
Relapse Risk Assessment in Early Phase Psychosis: The Search for a Reliable and Valid ToolThe Canadian Journal of Psychiatry, 59
R. Vauth, N. Rüsch, M. Wirtz, P. Corrigan (2004)
Does social cognition influence the relation between neurocognitive deficits and vocational functioning in schizophrenia?Psychiatry Research, 128
D. Mueller, S. Schmidt, V. Roder (2015)
One-year randomized controlled trial and follow-up of integrated neurocognitive therapy for schizophrenia outpatients.Schizophrenia bulletin, 41 3
Deirdre Robertson, A. Hargreaves, E. Kelleher, D. Morris, M. Gill, A. Corvin, G. Donohoe (2013)
Social dysfunction in schizophrenia: An investigation of the GAF scale's sensitivity to deficits in social cognitionSchizophrenia Research, 146
J. Kane, S. Leucht, D. Carpenter, J. Docherty (2003)
The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.The Journal of clinical psychiatry, 64 Suppl 12
R. Zipursky, Natasja Menezes, D. Streiner (2014)
Risk of symptom recurrence with medication discontinuation in first-episode psychosis: A systematic reviewSchizophrenia Research, 152
D. Windell, R. Norman, A. Malla (2012)
The personal meaning of recovery among individuals treated for a first episode of psychosis.Psychiatric services, 63 6
V. Roder, D. Mueller, S. Schmidt (2011)
Effectiveness of integrated psychological therapy (IPT) for schizophrenia patients: a research update.Schizophrenia bulletin, 37 Suppl 2
K. Higashi, G. Medic, Kavi Littlewood, T. Díez, O. Granström, M. Hert (2013)
Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature reviewTherapeutic Advances in Psychopharmacology, 3
J. Csernansky, Ramy Mahmoud, R. Brenner (2002)
A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia.The New England journal of medicine, 346 1
M. Cella, T. Wykes (2017)
The nuts and bolts of Cognitive Remediation: Exploring how different training components relate to cognitive and functional gainsSchizophrenia Research, 203
N. Frommann, M. Streit, W. Wölwer (2003)
Remediation of facial affect recognition impairments in patients with schizophrenia: a new training programPsychiatry Research, 117
J. Gold, C. Carpenter, C. Randolph, T. Goldberg, D. Weinberger (1997)
Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia.Archives of general psychiatry, 54 2
T. Muramatsu (2011)
[Wisconsin Card Sorting Test (WCST)].Nihon rinsho. Japanese journal of clinical medicine, 69 Suppl 8
J. Tao, Q. Zeng, Jia-Yong Liang, A. Zhou, Xuebing Yin, Aihong Xu (2015)
Effects of cognitive rehabilitation training on schizophrenia: 2 years of follow-up.International journal of clinical and experimental medicine, 8 9
(1986)
1986)WIP: Handbuch zum Reduzierten Wechsler- Intelligenztest; Anwendung, Auswertung, statistische Analysen, Normwerte
S. Leucht, M. Tardy, K. Komossa, S. Heres, Werner Kissling, G. Salanti, John Davis (2012)
Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysisThe Lancet, 379
M. Hoe, Eri Nakagami, Michael Green, J. Brekke (2012)
The causal relationships between neurocognition, social cognition and functional outcome over time in schizophrenia: a latent difference score approachPsychological Medicine, 42
D. Mueller, Z. Khalesi, V. Benzing, Clelia Castiglione, V. Roder (2017)
Does Integrated Neurocognitive Therapy (INT) reduce severe negative symptoms in schizophrenia outpatients?Schizophrenia Research, 188
G. Strauss, M. Harrow, L. Grossman, C. Rosen (2010)
Periods of recovery in deficit syndrome schizophrenia: a 20-year multi-follow-up longitudinal study.Schizophrenia bulletin, 36 4
Z. Khalesi, Michelle Jetha, K. Poole, J. Goldberg, R. Lieshout, L. Schmidt (2018)
Shyness, hormones, and quality of life among adults with schizophreniaInternational Journal of Neuroscience, 129
F. Naeem, B. Khoury, Tariq Munshi, M. Ayub, T. Lecomte, D. Kingdon, S. Farooq (2016)
Brief Cognitive Behavioral Therapy for Psychosis (CBTp) for Schizophrenia: Literature Review and Meta-analysisInternational Journal of Cognitive Therapy, 9
David Turner, Edel McGlanaghy, P. Cuijpers, M. Gaag, E. Karyotaki, A. MacBeth (2018)
A Meta-Analysis of Social Skills Training and Related Interventions for PsychosisSchizophrenia Bulletin, 44
Schizophr Res, 31
D. Mueller, S. Schmidt, V. Roder (2012)
Integrated psychological therapy: effectiveness in schizophrenia inpatient settings related to patients' age.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 21 3
M. Startup, Mike Jackson, Sue Bendix (2002)
The concurrent validity of the Global Assessment of Functioning (GAF).The British journal of clinical psychology, 41 Pt 4
Michael Green, K. Nuechterlein (1999)
Should schizophrenia be treated as a neurocognitive disorder?European Neuropsychopharmacology, 9
S. Kay, A. Fiszbein, L. Opler (1987)
The positive and negative syndrome scale (PANSS) for schizophrenia.Schizophrenia bulletin, 13 2
M. Cella, A. Preti, C. Edwards, Tabitha Dow, T. Wykes (2017)
Cognitive remediation for negative symptoms of schizophrenia: A network meta-analysis.Clinical psychology review, 52
T. Kishimoto, V. Agarwal, T. Kishi, S. Leucht, J. Kane, C. Correll (2011)
Relapse Prevention in Schizophrenia: A Systematic Review and Meta-Analysis of Second-Generation Antipsychotics versus First-Generation AntipsychoticsMolecular psychiatry, 18
Michael Green, B. Olivier, J. Crawley, D. Penn, S. Silverstein (2005)
Social cognition in schizophrenia: recommendations from the measurement and treatment research to improve cognition in schizophrenia new approaches conference.Schizophrenia bulletin, 31 4
D. Velligan, P. Weiden, M. Sajatovic, Jan Scott, D. Carpenter, R. Ross, J. Docherty (2009)
The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.The Journal of clinical psychiatry, 70 Suppl 4
Jacob Cohen (1969)
Statistical Power Analysis for the Behavioral SciencesThe SAGE Encyclopedia of Research Design
L. Alphs, H. Nasrallah, C. Bossie, D. Fu, S. Gopal, D. Hough, I. Turkoz (2016)
Factors associated with relapse in schizophrenia despite adherence to long-acting injectable antipsychotic therapyInternational Clinical Psychopharmacology, 31
M. Kurtz, Emily Gagen, N. Rocha, S. Machado, D. Penn (2016)
Comprehensive treatments for social cognitive deficits in schizophrenia: A critical review and effect-size analysis of controlled studies.Clinical psychology review, 43
R. Reitan (1958)
Validity of the Trail Making Test as an Indicator of Organic Brain DamagePerceptual and Motor Skills, 8
Meghan Bowtell, S. Eaton, K. Thien, Melissa Bardell-Williams, L. Downey, A. Ratheesh, E. Killackey, P. McGorry, B. O’Donoghue (2017)
Rates and predictors of relapse following discontinuation of antipsychotic medication after a first episode of psychosisSchizophrenia Research, 195
C. Correli (2012)
RELAPSE PREVENTION IN SCHIZOPHRENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF SECOND-GENERATION ANTIPSYCHOTICS VERSUS FIRST-GENERATION ANTIPSYCHOTICSSchizophrenia Research, 136
T. Wykes, V. Huddy, C. Cellard, S. McGurk, Pál Czobor (2011)
A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes.The American journal of psychiatry, 168 5
K. Nuechterlein, D. Barch, J. Gold, T. Goldberg, Michael Green, R. Heaton (2004)
Identification of separable cognitive factors in schizophreniaSchizophrenia Research, 72
(2012)
Evaluation eines neu entwickelten Fragebogen zur Emotionserkennung bei schizophren Erkrankten
N. Andreasen, W. Carpenter, J. Kane, R. Lasser, S. Marder, D. Weinberger (2005)
Remission in schizophrenia: proposed criteria and rationale for consensus.The American journal of psychiatry, 162 3
V. Roder, H. Brenner, Norbert Kienzle (2008)
Integriertes Psychologisches Therapieprogramm bei schizophren Erkrankten IPT
J. Olivares, J. Sermon, M. Hemels, A. Schreiner (2013)
Definitions and drivers of relapse in patients with schizophrenia: a systematic literature reviewAnnals of General Psychiatry, 12
R. Emsley, B. Chiliza, L. Asmal, B. Harvey (2013)
The nature of relapse in schizophreniaBMC Psychiatry, 13
(2010)
Test d2-Revision: Aufmerksamkeitsund Konzentrationstest
T. Lincoln, K. Wilhelm, Yvonne Nestoriuc (2007)
Effectiveness of psychoeducation for relapse, symptoms, knowledge, adherence and functioning in psychotic disorders: A meta-analysisSchizophrenia Research, 96
J Psychiatry
J. Krupnick (2012)
A Meta-Analysis of Cognitive Remediation for Schizophrenia: Methodology and Effect SizesYearbook of Psychiatry and Applied Mental Health, 2012
Mark Rosenberg (2009)
Diagnosis , Treatment Options , and Costs of Schizophrenia
F. Pharoah, J. Mari, J. Rathbone, W. Wong (2010)
Family intervention for schizophrenia.The Cochrane database of systematic reviews, 12
Emily Revell, J. Neill, M. Harte, Zarshed Khan, R. Drake (2015)
A systematic review and meta-analysis of cognitive remediation in early schizophreniaSchizophrenia Research, 168
Meghan Bowtell, A. Ratheesh, P. McGorry, E. Killackey, B. O’Donoghue (2017)
Clinical and demographic predictors of continuing remission or relapse following discontinuation of antipsychotic medication after a first episode of psychosis. A systematic reviewSchizophrenia Research, 197
B. Kovasznay (2012)
Integrated Psychological Therapy (IPT) for the Treatment of Neurocognition, Social Cognition, and Social Competency in Schizophrenia Patients
H. Remschmidt (2005)
Metaanalyse. Eine anwendungsorientierte Einführung.Zeitschrift Fur Kinder-und Jugendpsychiatrie Und Psychotherapie, 33
S. Leucht (2014)
Measurements of response, remission, and recovery in schizophrenia and examples for their clinical application.The Journal of clinical psychiatry, 75 Suppl 1
Mark Pennington, Paul McCrone (2017)
The Cost of Relapse in SchizophreniaPharmacoEconomics, 35
Michael Green, K. Nuechterlein (1999)
Should Schizophrenia Be Treated as a Neurocognitive DisorderSchizophrenia Bulletin, 25
S. McGurk, E. Twamley, D. Sitzer, G. McHugo, K. Mueser (2007)
A meta-analysis of cognitive remediation in schizophrenia.The American journal of psychiatry, 164 12
Shinichi Nakagawa (2004)
A farewell to Bonferroni: the problems of low statistical power and publication biasBehavioral Ecology, 15
Christopher Jones, D. Hacker, I. Cormac, A. Meaden, Claire Irving (2012)
Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia.The Cochrane database of systematic reviews, 4
J. Xia, L. Merinder, M. Belgamwar (2011)
Psychoeducation for schizophrenia.The Cochrane database of systematic reviews, 2
W. Trapp, M. Landgrebe, Katharina Hoesl, S. Lautenbacher, B. Gallhofer, W. Günther, G. Hajak (2013)
Cognitive remediation improves cognition and good cognitive performance increases time to relapse – results of a 5 year catamnestic study in schizophrenia patientsBMC Psychiatry, 13
R. Whitley, R. Drake (2010)
Recovery: a dimensional approach.Psychiatric services, 61 12
M. Kurtz, Kim Mueser (2008)
A meta-analysis of controlled research on social skills training for schizophrenia.Journal of consulting and clinical psychology, 76 3
Abstract International guidelines define relapse prevention for schizophrenia patients as a key therapeutic aim. However, approximately 80% to 90% of schizophrenia patients experience further symptom exacerbation after the first episode. The purpose of this study was to investigate whether group integrated neurocognitive therapy (INT), a cognitive remediation approach, reduces relapse rates in schizophrenia outpatients. INT was compared with treatment as usual (TAU) in a randomized controlled trial. Fifty-eight stabilized outpatients participated in the study with 32 allocated to the INT group and 26 to the TAU group. A test battery was used at baseline, posttreatment at 15 weeks, and a 1-year follow-up. Relapse rates were significantly lower in the INT condition compared with TAU during therapy as well as at follow-up. The relapse rate after therapy was associated with significant reductions in negative and general symptoms, improvements in functional outcome, and overall cognition. Out of these variables, negative symptoms were identified to show the strongest association with relapses after therapy. The primary outcome of this study suggests that INT can prevent relapses in schizophrenia outpatients.
Journal of Nervous & Mental Disease – Wolters Kluwer Health
Published: May 1, 2020
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.